These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 33968041)

  • 41. HIV Controllers Have Low Inflammation Associated with a Strong HIV-Specific Immune Response in Blood.
    Hocini H; Bonnabau H; Lacabaratz C; Lefebvre C; Tisserand P; Foucat E; Lelièvre JD; Lambotte O; Saez-Cirion A; Versmisse P; Thiébaut R; Lévy Y
    J Virol; 2019 May; 93(10):. PubMed ID: 30814287
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immune activation during acute HIV infection and the impact of early antiretroviral therapy.
    Krebs SJ; Ananworanich J
    Curr Opin HIV AIDS; 2016 Mar; 11(2):163-72. PubMed ID: 26599167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 45. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.
    Pallikkuth S; Sharkey M; Babic DZ; Gupta S; Stone GW; Fischl MA; Stevenson M; Pahwa S
    J Virol; 2015 Dec; 90(6):2718-28. PubMed ID: 26676775
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Establishment of a Novel Humanized Mouse Model To Investigate
    Flerin NC; Bardhi A; Zheng JH; Korom M; Folkvord J; Kovacs C; Benko E; Truong R; Mota T; Connick E; Jones RB; Lynch RM; Goldstein H
    J Virol; 2019 Mar; 93(6):. PubMed ID: 30626677
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-Treatment Controllers: Role in HIV "Cure" Research.
    Cockerham LR; Hatano H; Deeks SG
    Curr HIV/AIDS Rep; 2016 Feb; 13(1):1-9. PubMed ID: 26781112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HIV-1-Specific Chimeric Antigen Receptor T Cells Fail To Recognize and Eliminate the Follicular Dendritic Cell HIV Reservoir
    Ollerton MT; Berger EA; Connick E; Burton GF
    J Virol; 2020 May; 94(10):. PubMed ID: 32161179
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrin α
    Sivro A; Schuetz A; Sheward D; Joag V; Yegorov S; Liebenberg LJ; Yende-Zuma N; Stalker A; Mwatelah RS; Selhorst P; Garrett N; Samsunder N; Balgobin A; Nawaz F; Cicala C; Arthos J; Fauci AS; Anzala AO; Kimani J; Bagaya BS; Kiwanuka N; Williamson C; Kaul R; Passmore JS; Phanuphak N; Ananworanich J; Ansari A; Abdool Karim Q; Abdool Karim SS; McKinnon LR;
    Sci Transl Med; 2018 Jan; 10(425):. PubMed ID: 29367348
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pathophysiology of HIV related thrombocytopenia: an analysis of 41 patients.
    Domínguez A; Gamallo G; Garcia R; Lopez-Pastor A; Peña JM; Vazquez JJ
    J Clin Pathol; 1994 Nov; 47(11):999-1003. PubMed ID: 7829697
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Human Immunodeficiency Virus C.1086 Envelope gp140 Protein Boosts following DNA/Modified Vaccinia Virus Ankara Vaccination Fail To Enhance Heterologous Anti-V1V2 Antibody Response and Protection against Clade C Simian-Human Immunodeficiency Virus Challenge.
    Styles TM; Gangadhara S; Reddy PBJ; Hicks S; LaBranche CC; Montefiori DC; Derdeyn CA; Kozlowski PA; Velu V; Amara RR
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341049
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV-specific CD8⁺ T cells and HIV eradication.
    Jones RB; Walker BD
    J Clin Invest; 2016 Feb; 126(2):455-63. PubMed ID: 26731469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Platelets and erythrocyte-bound platelets bind infectious HIV-1 in plasma of chronically infected patients.
    Beck Z; Jagodzinski LL; Eller MA; Thelian D; Matyas GR; Kunz AN; Alving CR
    PLoS One; 2013; 8(11):e81002. PubMed ID: 24282562
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Magnitude and complexity of rectal mucosa HIV-1-specific CD8+ T-cell responses during chronic infection reflect clinical status.
    Critchfield JW; Young DH; Hayes TL; Braun JV; Garcia JC; Pollard RB; Shacklett BL
    PLoS One; 2008; 3(10):e3577. PubMed ID: 18974782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Kinetic studies of the mechanism of thrombocytopenia in patients with human immunodeficiency virus infection.
    Ballem PJ; Belzberg A; Devine DV; Lyster D; Spruston B; Chambers H; Doubroff P; Mikulash K
    N Engl J Med; 1992 Dec; 327(25):1779-84. PubMed ID: 1435932
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Blood CXCR3
    Banga R; Procopio FA; Ruggiero A; Noto A; Ohmiti K; Cavassini M; Corpataux JM; Paxton WA; Pollakis G; Perreau M
    Front Immunol; 2018; 9():144. PubMed ID: 29459864
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Herpes simplex virus type 1 and human immunodeficiency virus type 1 antigens in platelets from a hemophilia B patient with human immunodeficiency virus type 1-related thrombocytopenia.
    Koike K; Matsumoto K; Arai M; Yorifuji H; Fukutake K; Fujimaki M
    Int J Hematol; 1992 Apr; 55(2):205-10. PubMed ID: 1324748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Reduction of the HIV-1-infected T-cell reservoir by immune activation treatment is dose-dependent and restricted by the potency of antiretroviral drugs.
    Fraser C; Ferguson NM; Ghani AC; Prins JM; Lange JM; Goudsmit J; Anderson RM; de Wolf F
    AIDS; 2000 Apr; 14(6):659-69. PubMed ID: 10807189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.